1,261
Views
21
CrossRef citations to date
0
Altmetric
Review

Patient Preference and Satisfaction with the Use of Telemedicine for Glycemic Control in Patients with Type 2 Diabetes: A Review

ORCID Icon & ORCID Icon
Pages 283-298 | Published online: 10 Feb 2021

References

  • International Diabetes Federation. IDF Diabetes Atlas. 9th Edition. 2019.
  • Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–1788.
  • American Diabetes Association. Implications of the United Kingdom prospective diabetes study. Diabetes Care. 2002;25(suppl1):s28–s32. doi:10.2337/diacare.25.2007.S28
  • King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999;48(5):643–648. doi:10.1046/j.1365-2125.1999.00092.x
  • Rodríguez-Gutiérrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus: our evolving faith in the face of evidence. Circ Cardiovasc Qual Outcomes. 2016;9(5):504–512. doi:10.1161/CIRCOUTCOMES.116.002901
  • Harris M. Challenges in diabetes management. Aust Fam Physician. 2008;37(9):716–720.
  • Association AT. Telehealth basics. Available from: https://www.americantelemed.org/resource/why-telemedicine/. Accessed August 1, 2020.
  • Lee SWH, Ooi L, Lai YK. Telemedicine for the management of glycemic control and clinical outcomes of type 1 diabetes mellitus: a systematic review and meta-analysis of randomized controlled studies. Front Pharmacol. 2017;8:330. doi:10.3389/fphar.2017.00330
  • Lee SWH, Chan CKY, Chua SS, Chaiyakunapruk N. Comparative effectiveness of telemedicine strategies on type 2 diabetes management: a systematic review and network meta-analysis. Sci Rep. 2017;7(1):12680. doi:10.1038/s41598-017-12987-z
  • Chakranon P, Lai YK, Tang YW, Choudhary P, Khunti K, Lee SWH. Distal technology interventions in people with diabetes: an umbrella review of multiple health outcomes. Diabet Med. 2020;37(12):1966–1976. doi:10.1111/dme.14156
  • Chongmelaxme B, Lee S, Dhippayom T, Saokaew S, Chaiyakunapruk N, Dilokthornsakul P. The effects of telemedicine on asthma control and patients’ quality of life in adults: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019;7(1):199–216.e111. doi:10.1016/j.jaip.2018.07.015
  • Lee P, Greenfield G, Pappas Y. Patients’ Perception of Using Telehealth for Type 2 Diabetes Management: A Phenomenological Study. 2018.
  • Barbosa CD, Balp -M-M, Kulich K, Germain N, Rofail D. A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Prefer Adherence. 2012;6:39–48. doi:10.2147/PPA.S24752
  • Duke DC, Barry S, Wagner DV, Speight J, Choudhary P, Harris MA. Distal technologies and type 1 diabetes management. Lancet Diabetes Endocrinol. 2018;6(2):143–156. doi:10.1016/S2213-8587(17)30260-7
  • Fleming GA, Petrie JR, Bergenstal RM, Holl RW, Peters AL, Heinemann L. Diabetes digital app technology: benefits, challenges, and recommendations. a consensus report by the European association for the study of diabetes (EASD) and the American diabetes association (ADA) diabetes technology working group. Diabetologia. 2020;63(2):229–241. doi:10.1007/s00125-019-05034-1
  • Siminerio L, Ruppert K, Huber K, Toledo FG. Telemedicine for reach, education, access, and treatment (TREAT): linking telemedicine with diabetes self-management education to improve care in rural communities. Diabetes Educ. 2014;40(6):797–805. doi:10.1177/0145721714551993
  • Yip MP, Mackenzie A, Chan J. Patient satisfaction with telediabetes education in Hong Kong. J Telemed Telecare. 2002;8(1):48–51. doi:10.1258/1357633021937460
  • Long AF, Gambling T, Young RJ, Taylor J, Mason JM. Acceptability and satisfaction with a telecarer approach to the management of type 2 diabetes. Diabetes Care. 2005;28(2):283–289. doi:10.2337/diacare.28.2.283
  • Georgsson M, Staggers N. Quantifying usability: an evaluation of a diabetes mHealth system on effectiveness, efficiency, and satisfaction metrics with associated user characteristics. J Am Med Inform Assoc. 2016;23(1):5–11. doi:10.1093/jamia/ocv099
  • Gabarron E, Dorronzoro E, Bradway M, Rivera-Romero O, Wynn R, Årsand E. Preferences and interests of diabetes social media users regarding a health-promotion intervention. Patient Prefer Adherence. 2018;12:2499–2506. doi:10.2147/PPA.S184369
  • Veazie SWK, Gilbert J, Paynter R, et al. Mobile Applications for Self-Management of Diabetes. Technical Brief No. 31. (Prepared by the Scientific Resource Center Under Contract Nos. 290-2012-0004-C and 290-2017-00003-C). AHRQ Publication No 18-EHC010-EF Rockville, MD. Agency for Healthcare Research and Quality; 2018.
  • Jeffrey B, Bagala M, Creighton A, et al. Mobile phone applications and their use in the self-management of type 2 diabetes mellitus: a qualitative study among app users and non-app users. Diabetol Metab Syndr. 2019;11(1):84. doi:10.1186/s13098-019-0480-4
  • Lee JY, Chan CKY, Chua SS, et al. Using telemedicine to support care for people with type 2 diabetes mellitus: a qualitative analysis of patients’ perspectives. BMJ Open. 2019;9(10):e026575–e026575. doi:10.1136/bmjopen-2018-026575
  • Rodríguez-Fortúnez P, Franch-Nadal J, Fornos-Pérez JA, Martínez-Martínez F, de Paz HD, Orera-Peña ML. Cross-sectional study about the use of telemedicine for type 2 diabetes mellitus management in Spain: patient’s perspective. The EnREDa2 study. BMJ Open. 2019;9(6):e028467. doi:10.1136/bmjopen-2018-028467
  • Wade-Vuturo AE, Mayberry LS, Osborn CY. Secure messaging and diabetes management: experiences and perspectives of patient portal users. J Am Med Inform Assoc. 2012;20(3):519–525. doi:10.1136/amiajnl-2012-001253
  • Rho MJ, Kim SR, Kim HS, et al. Exploring the relationship among user satisfaction, compliance, and clinical outcomes of telemedicine services for glucose control. Telemed J E Health. 2014;20(8):712–720. doi:10.1089/tmj.2013.0309
  • Gordon HS, Solanki P, Bokhour BG, Gopal RK. I’m not feeling like i’m part of the conversation patients’ perspectives on communicating in clinical video telehealth visits. J Gen Intern Med. 2020;35(6):1751–1758. doi:10.1007/s11606-020-05673-w
  • Center PR. Tech Adoption Climbs Among Older Adults. 2017.
  • Torbjørnsen A, Ribu L, Rønnevig M, Grøttland A, Helseth S. Users’ acceptability of a mobile application for persons with type 2 diabetes: a qualitative study. BMC Health Serv Res. 2019;19(1):641. doi:10.1186/s12913-019-4486-2
  • Buysse H, Coremans P, Pouwer F, Ruige J. Sustainable improvement of HbA1c and satisfaction with diabetes care after adding telemedicine in patients on adaptable insulin regimens: results of the TeleDiabetes randomized controlled trial. Health Informatics J. 2019;26(1):628–641. doi:10.1177/1460458219844369
  • Baptista S, Trawley S, Pouwer F, Oldenburg B, Wadley G, Speight J. What do adults with type 2 diabetes want from the “perfect” app? Results from the second diabetes MILES: Australia (MILES-2) study. Diabetes Technol Ther. 2019;21(7):393–399. doi:10.1089/dia.2019.0086
  • Adu MD, Malabu UH, Malau-Aduli AEO, Malau-Aduli BS. Users’ preferences and design recommendations to promote engagements with mobile apps for diabetes self-management: multi-national perspectives. PLoS One. 2018;13(12):e0208942. doi:10.1371/journal.pone.0208942
  • Lee JY, Lee SWH. Telemedicine cost-effectiveness for diabetes management: a systematic review. Diabetes Technol Ther. 2018;20(7):492–500. doi:10.1089/dia.2018.0098
  • Boels AM, Vos RC, Hermans TGT, et al. What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries. BMJ Open. 2017;7(7):e016180. doi:10.1136/bmjopen-2017-016180
  • Andrews SM, Sperber NR, Gierisch JM, et al. Patient perceptions of a comprehensive telemedicine intervention to address persistent poorly controlled diabetes. Patient Prefer Adherence. 2017;11:469–478. doi:10.2147/PPA.S125673
  • Lopez JMS, Katic BJ, Fitz-Randolph M, Jackson RA, Chow W, Mullins CD. Understanding preferences for type 2 diabetes mellitus self-management support through a patient-centered approach: a 2-phase mixed-methods study. BMC Endocr Disord. 2016;16(1):41. doi:10.1186/s12902-016-0122-x
  • Kebede MM, Pischke CR, Popular D. Apps and the impact of diabetes app use on self-care behaviour: a survey among the digital community of persons with diabetes on social media. Front Endocrinol (Lausanne). 2019;10:135. doi:10.3389/fendo.2019.00135
  • McMillan KA, Kirk A, Hewitt A, MacRury S. A systematic and integrated review of mobile-based technology to promote active lifestyles in people with type 2 diabetes. J Diabetes Sci Technol. 2017;11(2):299–307. doi:10.1177/1932296816656018
  • Ronda MCM, Dijkhorst-Oei L-T, Rutten GEHM. Patients’ experiences with and attitudes towards a diabetes patient web portal. PLoS One. 2015;10(6):e0129403–e0129403. doi:10.1371/journal.pone.0129403
  • Welch G, Balder A, Zagarins S. Telehealth program for type 2 diabetes: usability, satisfaction, and clinical usefulness in an urban community health center. Telemed J E Health. 2015;21(5):395–403. doi:10.1089/tmj.2014.0069
  • El-Gayar O, Timsina P, Nawar N, Eid W. Mobile applications for diabetes self-management: status and potential. J Diabetes Sci Technol. 2013;7(1):247–262. doi:10.1177/193229681300700130
  • Center PR. Mobile Technology and Home Broadband 2019. 2019.
  • Martinez PR. A Qualitative Study on Patient Perceptions Towards mHealth Technology Among High Risk, Chronic Disease Patients. 2015.
  • Byambasuren O, Beller E, Glasziou P. Current knowledge and adoption of mobile health apps among Australian general practitioners: survey study. JMIR Mhealth Uhealth. 2019;7(6):e13199–e13199. doi:10.2196/13199
  • Liu Y, Ren W, Qiu Y, Liu J, Yin P, Ren J. The use of mobile phone and medical apps among general practitioners in Hangzhou City, Eastern China. JMIR Mhealth Uhealth. 2016;4(2):e64–e64. doi:10.2196/mhealth.4508
  • Sun R, Burke LE, Saul MI, Korytkowski MT, Li D, Sereika SM. Use of a patient portal for engaging patients with type 2 diabetes: patterns and prediction. Diabetes Technol Ther. 2019;21(10):546–556. doi:10.1089/dia.2019.0074
  • Reed ME, Huang J, Graetz I, et al. Patient characteristics associated with choosing a telemedicine visit vs office visit with the same primary care clinicians. JAMA Netw Open. 2020;3(6):e205873–e205873. doi:10.1001/jamanetworkopen.2020.5873
  • Park H, Chon Y, Lee J, Ie J C, Yoon KH. Service design attributes affecting diabetic patient preferences of telemedicine in South Korea. Telemed J E Health. 2011;17(6):442–451. doi:10.1089/tmj.2010.0201
  • Röhling M, Redaélli M, Simic D, et al. TeDia - a telemedicine-based treatment model for inpatient and interprofessional diabetes care. Diabetes Metab Syndr Obes. 2019;12:2479–2487. doi:10.2147/DMSO.S229933
  • Leigh S, Ashall-Payne L. The role of health-care providers in mHealth adoption. Lancet Glob Health. 2019;1(2):e58–e59. doi:10.1016/S2589-7500(19)30025-1
  • Nguyen M, Waller M, Pandya A, Portnoy JA. Review of patient and provider satisfaction with telemedicine. Curr Allergy Asthma Rep. 2020;20(11):72. doi:10.1007/s11882-020-00969-7
  • Unnikrishnan AG. Artificial intelligence in health care: focus on diabetes management. Indian J Endocrinol Metab. 2019;23(5):503–506. doi:10.4103/ijem.IJEM_549_19
  • Doraiswamy S, Abraham A, Mamtani R, Cheema S. Use of telehealth during the COVID-19 pandemic: scoping review. J Med Internet Res. 2020;22(12):e24087. doi:10.2196/24087
  • Koonin L, Hoots B, Tsang C, et al. Trends in the use of telehealth during the emergence of the COVID-19 pandemic — United States, january–march 2020. MMWR Morb Mortal Wkly Rep. 2020;69(43):1595–1599. doi:10.15585/mmwr.mm6943a3